Have a personal or library account? Click to login
Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective Cover

Basal Cell Carcinoma Aggressiveness, Molecular Factors And Therapy: A Clinician Perspective

Open Access
|Feb 2013

References

  1. 1. Dimitrescu Al.,Trifu P. (1992) Precancerele SiCancerele Cutanate Vol I Pag 9-26,149-185., Ed. Medicala, Bucuresti.
  2. 2. Green A, Battistutad,Hart V .S (1996). Cancer In A Subtropical Australian Population. Thenambour Study Group. Am J Epidemiol; 144:1034-1040.10.1093/oxfordjournals.aje.a008875
  3. 3. Morarul (1980). Anatomiepatologică vol II. Ed. Medicala, Bucuresti.
  4. 4. Rahbari H, Mehregan Ah. (1982) Basal Cell Epithelioma (Carcinoma) In Children And Teenagers. Cancer ;49:350-363.10.1002/1097-0142(19820115)49:2<;350::AID-CNCR2820490223>3.0.CO;2-Y
  5. 5. Ji R C. (2006) Lymphatic Endothelial Cells, Lymphangiogenesis, And Extracellular Matrix. Lymphat Res Biol. ;4(2):83-100.10.1089/lrb.2006.4.83
  6. 6. Cruse P.J.E., Mcphedran N.T. (1987) Wound Healing Andmanagement. In:„Sabiston’sTextbook Of Surgery”, Editia A 14-A. W. B. Saunders Company, Philadelphia : 117-121.
  7. 7. Walling Hw, Fosko Sw, Geraminejad Pa, Whitaker Dc, Arpey Cj. (2004) Aggressive Basal Cell Carcinoma: Presentation, Pathogenesis, And Management. Cancer Metastasis Rev. ;23(3-4):389-402.10.1023/B:CANC.0000031775.04618.30
  8. 8. Scanlan D, Radio Sj, Nelson M, Zhou M, Streblow R, Prasad V, Reyes C, Perry D, Fletcher S, Bridge Ja. (2008) Loss Of The Ptch1 Gene Locus In Cardiac Fibroma.Cardiovascpathol.17(2):93-7.10.1016/j.carpath.2007.08.001
  9. 9. Weiss Gj, Korn Rl. (2012) Metastatic Basal Cell Carcinoma In The Era Of Hedgehog Signaling Pathway Inhibitors.Cancer.10.1002/cncr.27532
  10. 10. Ting Pt, Kasper R, Arlette Jp. (2005)Metastatic Basal Cell Carcinoma: Report Of Two Cases And Literature Review. J Cutan Med Surg. (1):10-5.10.1177/120347540500900104
  11. 11. Young Lc, Listgarten J, Trotter Mj, Andrew Se, Tron Va. (2008) Evidence That Dysregulated Dna Mismatch Repair Characterizes Human Nonmelanoma Skin Cancer. Br J Dermatol. 158(1):59-69.
  12. 12. Howell Bg, Solish N, Lu C, Watanabe H, Mamelak Aj, Freed I, Wang B, Sauder Dn. (2005) Microarray Profiles Of Human Basal Cell Carcinoma: Insights Into Tumor Growth And Behavior. J Dermatol Sci.39(1):39-51. Epub 2005 Apr 18.10.1016/j.jdermsci.2005.02.004
  13. 13. Zhang M, Liang L, Morar N, Dixon Al, Lathrop Gm, Ding J, Moffatt Mf, Cookson Wo, Kraft P, Qureshi Aa, Han J. (2012) Integrating Pathway Analysis And Genetics Of Gene Expression For Genome-Wide Association Study Of Basal Cell Carcinoma. Hum Genet.;131(4):615-23.10.1007/s00439-011-1107-5
  14. 14. Bale Ae, Yu Kp. (2001) The Hedgehog Pathway And Basal Cell Carcinomas. Hum Mol Genet. 10(7):757-62.10.1093/hmg/10.7.757
  15. 15. Wicking C, Mcglinn E. (2001) The Role Of Hedgehog Signalling In Tumorigenesis.Cancer Lett.173(1):1-7.10.1016/S0304-3835(01)00676-0
  16. 16. Zhang H, Ping Xl, Lee Pk, Wu Xl, Yao Yj, Zhang Mj, Et Al.(2001) Role Of Ptch And P53 Genes In Early-Onset Basal Cell Carcinoma. Am J Pathol. 158(2):381-5.10.1016/S0002-9440(10)63980-6
  17. 17. Weinstein Mc, Brodell Rt, Bordeaux J, Honda K. (2012) The Art And Science Of Surgical Margins For The Dermatopathologist.Am JDermatopathol. 34(7):737-45.10.1097/DAD.0b013e31823347cb
  18. 18. Ferrandiz L, Ruiz-De-Casas A, Trakatelli M, De Vries E, Ulrich M, Aquilina S, Saksela O, Majewski S, Ranki A, Proby C, Magnoni C, Pitkänen S, Kalokasidis K, Siskou S, Hinrichs B, Altsitsiadis E, Stockfleth E, Moreno-Ramirez D; Epiderm Group. (2012) Assessing Physicians’ Preferences On Skin Cancer Treatment In Europe.Br J Dermatol. 67suppl 2:29-35.10.1111/j.1365-2133.2012.11084.x
  19. 19. Messeguer F, Serra-Guillen C, Echeverria B, Requena C, Sanmartin O, Llombart B, Guillen C, Nagore E. (2012) A Pilot Study Of Clinical Efficacy Of Imiquimod And Cryotherapy For The Treatment Of Basal Cell Carcinoma With Incomplete Response To Imiquimod.JEuracaddermatolvenereol. ;26(7):879-81.10.1111/j.1468-3083.2011.04177.x
  20. 20. Olschewski T, Bajor K, Lang B, Lang E, Seegenschmiedt Mh. (2006) Radiotherapy Of Basal Cell Carcinoma Of The Face And Head: Importance Of Low Dose Per Fraction On Long- Term Outcome. J Dtschdermatolges. 4(2):124-30.10.1111/j.1610-0387.2006.05880.x
  21. 21. Mendenhall Wm, Amdur Rj, Hinerman Rw, Cognetta Ab, Mendenhall Np. (2009) Radiotherapy For Cutaneous Squamous And Basal Cell Carcinomas Of The Head And Neck. Laryngoscope. 119(10):1994-910.1002/lary.20608
  22. 22. De Vijlder Hc, Sterenborg Hj, Neumann Ha, Robinson Dj, De Haas Er. (2012) Light Fractionation Significantly Improves The Response Of Superficial Basal Cell Carcinoma To Aminolaevulinic Acid Photodynamic Therapy: Five-Year Follow-Up Of A Randomized, Prospective Trial. Acta Derm Venereol. 17;92(6):641-7.10.2340/00015555-1448
  23. 23. Puccioni M, Santoro N, Giansanti F, Ucci F, Rossi R, Lotti T, Et Al. (2009) Photodynamic Therapy Using Methyl Aminolevulinate Acid In Eyelid Basal Cell Carcinoma: A 5-Year Follow-Up Study. Ophthalplastreconstr Surg.;25(2):115-810.1097/IOP.0b013e31819a4404
  24. 24. Moore Ay. (2009) Clinical Applications For Topical 5-Fluorouracil In The Treatment Of Dermatological Disorders.J Dermatolog Treat. 20(6):328-35.10.3109/09546630902789326
  25. 25. Miller Bh, Shavin Js, Cognetta A, Taylor Rj, Salasche S, Korey A, Et Al. (1997) Nonsurgical Treatment Of Basal Cell Carcinomas With Intralesional 5-Fluorouracil/Epinephrine Injectable Gel. J Am Acad Dermatol.36(1):72-710.1016/S0190-9622(97)70328-1
  26. 26. Drehs Mm, Cook-Bolden F, Tanzi El, Weinberg Jm. (2002) Successful Treatment Of Multiple Superficial Basal Cell Carcinomas With Topical Imiquimod: Case Report And Review Of The Literature. Dermatol Surg. 28(5):427-910.1046/j.1524-4725.2002.01231.x
  27. 27. Tandon Y, Brodell Rt. (2012) Local Reactions To Imiquimod In The Treatment Of Basal Cell Carcinoma. Dermatol Online J. 15;18(9):1.10.5070/D36DM013FJ
  28. 28. Van Der Geer S, Martens J, Van Roij J, Brand E, Ostertag Ju, Verhaegh Me, Neumann Ha, Krekels Ga. (2012) Imiquimod 5% Cream As Pretreatment Of Mohs Micrographic Surgery For Nodular Basal Cell Carcinoma In The Face: A Prospective Randomized Controlled Study. BrJ Dermatol. 67(1):110-5.10.1111/j.1365-2133.2012.10924.x22385074
  29. 29. So Pl, Fujimoto Ma, Epstein Eh Jr. (2008) Pharmacologic Retinoid Signaling And Physiologic Retinoic Acid Receptor Signaling Inhibit Basal Cell Carcinoma Tumorigenesis. Mol Cancer Ther. 7(5):1275-8410.1158/1535-7163.MCT-07-2043
  30. 30. Bianchi L, Orlandi A, Campione E, Angeloni C, Costanzo A, Spagnoli Lg, Chimenti S. (2004) Topical Treatment Of Basal Cell Carcinoma With Tazarotene: A Clinicopathological Study On A Large Series Of Cases. Br J Dermatol. 151(1):148-5610.1111/j.1365-2133.2004.06044.x15270884
DOI: https://doi.org/10.2478/v10307-012-0011-0 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Language: English
Page range: 54 - 61
Published on: Feb 26, 2013
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2013 D. Dorobanţu, Mihaela Opriş, Georgeta Liliana Cif, C. Trâmbiţaş, L. Seres Sturm, E. B. Petcu, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.